Đang chuẩn bị liên kết để tải về tài liệu:
Pre-clinical study of IRDye800CWnimotuzumab formulation, stability, pharmacokinetics, and safety

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Epidermal growth factor receptor (EGFR) is a target for cancer therapy as it is overexpressed in a wide variety of cancers. Therapeutic antibodies that bind EGFR are being evaluated in clinical trials as imaging agents for positron emission tomography and image-guided surgery. |

TÀI LIỆU LIÊN QUAN

Preclinical pharmacokinetics study of R- and S-Enantiomers of the histone deacetylase inhibitor, AR-42 (NSC 731438), in rodents

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

Báo cáo khoa học: "Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study"

Báo cáo y học: "High-molecular-weight hyaluronan – a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats"

Báo cáo sinh học: " Analysis of machine perfusion benefits in kidney grafts: a preclinical study"

báo cáo hóa học:" Analysis of machine perfusion benefits in kidney grafts: a preclinical study"

ADVANCES IN THE PRECLINICAL STUDY OF ISCHEMIC STROKE

Population Ageing, Elderly Welfare, and Extending Retirement Cover: The Case Study of Sri Lanka

An e-Health System for the Elderly (Butler Project): A Pilot Study on Acceptance and Satisfaction

Remittances from Germany and their Routes to Migrants' Origin Countries: A study on five selected countries
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.